First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

A study of 108 adults finds that the vaccine produced neutralizing antibodies and T-cell response against SARS-CoV-2, but further research is needed to confirm whether the vaccine protects against SARS-COV-2 infection.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/05/200522113708.htm